Press Releases
Date Title and Summary View
Mar 15, 2017 MINNEAPOLIS, March 15, 2017 (GLOBE NEWSWIRE) -- Skyline Medical Inc. (NASDAQ:SKLN) ("Skyline" or "the Company"), developer of the innovative STREAMWAY® waste fluid disposal system for medical applications, reports financial results for the three and 12 months ended December 31, 2016 and provides a business ...
Mar 09, 2017 MINNEAPOLIS, March 09, 2017 (GLOBE NEWSWIRE) -- Skyline Medical Inc. (NASDAQ:SKLN) ("Skyline" or "the Company"), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, announced today that management will hold a conference call on March 15, 2017  to provid...
Mar 01, 2017 MINNEAPOLIS, March 01, 2017 (GLOBE NEWSWIRE) -- Skyline Medical Inc. (NASDAQ:SKLN) ("Skyline" or "the Company"),producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal has received an Innovative Technology contract  from ...
Feb 22, 2017 MINNEAPOLIS, Feb. 22, 2017 (GLOBE NEWSWIRE) -- Skyline Medical Inc. (NASDAQ:SKLN) ("Skyline" or "the Company"), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, today announced that Dawson James Securities, Inc., the underwriter of its previously annou...
Feb 17, 2017 MINNEAPOLIS, Feb. 17, 2017 (GLOBE NEWSWIRE) -- Skyline Medical, Inc. (NASDAQ:SKLN) today announced that it has received formal notice from The NASDAQ Stock Market LLC ("Nasdaq") indicating that the Company has evidenced full compliance with all requirements for continued listing on The Nasdaq Capital Market, and that the Comp...
Jan 26, 2017 MINNEAPOLIS, Jan. 26, 2017 (GLOBE NEWSWIRE) -- Skyline Medical Inc. (NASDAQ:SKLN) ("Skyline" or "the Company"), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, announces that stockholders have approved an amendment of the Company's certificate of inco...
Jan 13, 2017 MINNEAPOLIS, Jan. 13, 2017 (GLOBE NEWSWIRE) -- Skyline Medical Inc. (NASDAQ:SKLN) ("Skyline" or "the Company"), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, today announced the pricing of a firm commitment underwritten public offering of 1,750,000 Units at an offering price of $2.25 pe...
Jan 12, 2017 MINNEAPOLIS, Jan. 12, 2017 (GLOBE NEWSWIRE) -- Skyline Medical Inc. (NASDAQ:SKLN) ("Skyline" or "the Company"), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, announced today that management will hold a conference call on January 19, 2017  to pr...
Dec 29, 2016 MINNEAPOLIS, Dec. 29, 2016 (GLOBE NEWSWIRE) -- Skyline Medical Inc. (NASDAQ:SKLN) ("Skyline" or "the Company"), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, announces the Nasdaq Hearings Panel (the "Panel") has granted the Company's request for con...
Dec 02, 2016 MINNEAPOLIS, Dec. 02, 2016 (GLOBE NEWSWIRE) -- Skyline Medical Inc. (NASDAQ:SKLN) ("Skyline" or "the Company"), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, today announced changes in executive management and the board of directors.  Dr. Carl ...
Page:
1
... NextLast
= add release to Briefcase